Published: Wednesday, July 2, 2014
The American Herbal Products Association (AHPA) presented a two-hour educational teleseminar, “FDA Inspections and Emerging cGMP Compliance Issues for Dietary Supplements,” on Thursday, May 15, 2014.
A regularly occurring event and part of the association’s cGMP Compliance Series, this two-hour, audio-only teleseminar is designed to help businesses in the dietary supplement industry understand the elements of 21 CFR 111/current Good Manufacturing Practices (cGMP) regulations that are most focused on during recent FDA inspections. This knowledge will assist business with better allocating their compliance resources.
Veteran industry legal experts provide attendees with an insider’s view of current cGMP enforcement landscape. AHPA staff offers a detailed analysis of the association’s repository of inspection data, widely regarded as the most in-depth in the industry and which includes actual FDA 483 Inspection reports, Observation forms, and establishment inspection reports (EIRs).
2020 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.